Leave Your Message
-
Phone
-
E-mail
-
Whatsapp
-
Wechat
The medical industry has witnessed a transformative shift in material science, with transparent PVC granules emerging as a cornerstone material for critical healthcare applications. These specialized polymer compounds represent the convergence of biocompatibility, transparency, flexibility, and durability—qualities essential for modern medical device manufacturing.
Transparent PVC granules for medical applications are engineered to meet stringent regulatory standards including FDA, ISO 10993, and European Pharmacopoeia requirements. The material's exceptional clarity allows for visual inspection of contents, while its chemical resistance ensures compatibility with various pharmaceutical compounds and sterilization methods.
The global medical PVC market is projected to reach $2.8 billion by 2028, growing at a CAGR of 6.2%. This growth is driven by increasing demand for disposable medical devices, rising healthcare expenditure in emerging markets, and continuous innovation in polymer formulation technologies.
Our transparent PVC granules undergo rigorous biocompatibility testing per ISO 10993 standards, ensuring safe contact with human tissue, blood, and pharmaceutical compounds without adverse reactions.
Exceptional transparency with light transmittance exceeding 90%, enabling precise visual monitoring of fluid levels, medication dosage, and contamination detection in medical devices.
Superior resistance to pharmaceuticals, disinfectants, and bodily fluids, maintaining structural integrity and clarity throughout the product lifecycle.
Compatible with multiple sterilization methods including gamma radiation, ethylene oxide (EtO), and steam autoclave, without compromising material properties.
Fully compliant with FDA 21 CFR 177.1975, European Pharmacopoeia, USP Class VI, and RoHS directives, ensuring global market acceptance.
Excellent processing characteristics for injection molding, extrusion, blow molding, and thermoforming, enabling diverse product applications.
Transparent PVC granules are extensively used in manufacturing IV bags, tubing, and connectors. The material's flexibility prevents kinking while maintaining flow integrity, and its transparency allows healthcare professionals to monitor fluid administration, detect air bubbles, and verify medication mixing. The non-reactive nature ensures drug stability during storage and administration, critical for patient safety.
Medical-grade PVC granules form the foundation for blood bags, plasma containers, and transfusion sets. The material's gas permeability characteristics can be precisely controlled to maintain optimal oxygen and carbon dioxide levels, essential for blood preservation. Anti-coagulant compatibility and low platelet adhesion properties make it ideal for hematological applications.
Specialized transparent PVC formulations for urine bags and drainage systems offer superior puncture resistance and weldability. The material's clarity enables accurate volume measurement and visual inspection for abnormalities. Anti-reflux valve integration and odor-barrier properties enhance patient comfort and clinical utility.
Breathing circuits, oxygen masks, and anesthesia bags manufactured from transparent PVC granules provide critical visibility of condensation and secretions. The material's flexibility at body temperature ensures patient comfort, while its resilience maintains airway patency. Low extractable levels prevent contamination of breathing gases.
Hemodialysis and peritoneal dialysis solutions utilize transparent PVC for tubing and solution bags. The material's dimensional stability under fluid pressure, combined with its compatibility with dialysate solutions, ensures reliable long-term performance. Transparency facilitates monitoring of fluid clarity and flow rates.
Feeding tubes, nutrient solution bags, and administration sets benefit from PVC's flexibility and transparency. The material's resistance to lipid absorption maintains nutritional integrity, while its clarity allows verification of formula consistency and detection of contamination.
Post-operative drainage bags and wound drainage systems manufactured from transparent PVC enable precise monitoring of fluid output volume and characteristics. The material's puncture resistance and secure connection capabilities minimize leakage risks.
Blister packs, medication pouches, and pharmaceutical vials utilize transparent PVC for product visibility and tamper evidence. The material's moisture barrier properties and compatibility with various printing technologies support regulatory labeling requirements.
Bio-Based PVC Alternatives: Research into bio-based plasticizers and renewable feedstocks is accelerating, with several manufacturers developing partially bio-based PVC formulations that maintain medical-grade performance while reducing environmental impact. These innovations address sustainability concerns without compromising safety or functionality.
Smart Medical Devices Integration: The convergence of transparent PVC materials with embedded sensors and RFID technology is creating intelligent medical devices capable of real-time monitoring. Transparent conductive PVC formulations are enabling touch-sensitive surfaces and integrated diagnostic capabilities.
Antimicrobial Formulations: Advanced PVC granules incorporating silver nanoparticles, copper ions, or quaternary ammonium compounds provide inherent antimicrobial properties, reducing healthcare-associated infection risks. These formulations maintain transparency while offering continuous surface protection.
Enhanced Recyclability: New formulation technologies are improving PVC recyclability in medical applications, addressing end-of-life concerns. Chemical recycling processes are being developed to recover high-purity PVC from medical waste streams, supporting circular economy initiatives.
Regulatory Evolution: Stricter regulations regarding phthalate plasticizers have driven innovation in alternative plasticizer systems. Non-phthalate formulations using citrates, adipates, and trimellitates are becoming standard, offering equivalent or superior performance with improved safety profiles.
Customization and Precision Manufacturing: Advanced compounding technologies enable precise control over material properties, allowing manufacturers to tailor PVC granules for specific medical applications. This customization extends to hardness gradients, color coding, and functional additives.
Jiangsu Dahai Plastics Co., Ltd. was founded in 1996, is a professional production of various types of PVC film and printing PVC film technology of private enterprises. We mainly produce super transparent film, ordinary transparent film, toy film, bath film, raincoat film, electrical tape film, cold film, non-stick film, decorative film, PEVA film, particles, tablecloth, shower curtain, urine bag.
The company has more than 20 production lines, more than 450 employees, of which 30% are technical management personnel, and has a sound management system. Covers an area of more than 120,000 square meters, annual output of more than 100,000 tons, annual sales of more than 1 billion. The company continues to introduce advanced production equipment and technology. The product quality reaches the international standard, the company's products not only sell well in the domestic market, but also exported to South America, Southeast Asia, Africa and other places.
We possess laboratories accredited by China National Commission for Conformity Assessment (CNAS), which are equipped with many kinds of world advanced experimental equipment and physical and chemical testing-analysis instruments. In every experiment, in every test, even the slightest difference can be detected by our machines, which greatly guarantees the quality of our products.
DAHAI continues to invest resources, and we will work with university teams to develop products. Our technical department is constantly learning new technologies and combining them with our own situation, through which our ability to innovate is keeping improving.
The total registered capital of several projects under the company group is 40 million dollar, total assets reach 140 million dollar, floor area is more than 120000sqm, with 20 imported environmental protection production lines, with an annual production capacity of 150,000 tons. In year 2018, we achieved sales of 180 million dollar, of which exports earned 10 million US dollars. The products are sold to more than 400 cities in 12 provinces and regions across the country, the market share ranks first among private enterprises in the province, and the products are exported to more than 10 countries and regions. In view of the market development trend and the future development of the company, it is proposed to build an intelligent manufacturing project of new medical materials.
Make green materials, create a good and healthy life!
To become the domestic polymer material application industry leader, to build a world-class brand!
Independent innovation intelligent future! Team style: people-oriented safety first!
Integrity, pragmatic, efficient, win-win!
Tongzhou Huaming Plastic Co., Ltd. was established.
Tongzhou Huaming Plastics Co., Ltd. was changed to Jiangsu Dahai Plastics Co., LTD.
Nantong Runyang Plastic Co., Ltd. was established.
Dahai Real Estate Development Co., Ltd. was established.
Field E-commerce company is established.
Jiangyin Zhonglian Real Estate company was established.
Jiangyin Huayue Real Estate Development Co., Ltd. was established.
Jiangsu Houbang Industrial Co., LTD. was established.
We import all kinds of testing machines, such as universal testing machines, Agilent GC analyzers, gloss meters and cold-tolerance testing machines. Besides, we establish good cooperation with professional testing companies to meet customer's requirements. All of our products can meet the requirements of EN-71, ASTM-F-963, Model Toxics in Packaging Legislation (CONEG) and RoHS.
